The Road to Rome

Gastroenterology

Volumn 130, Issue 5, 2006, Pages 1552-1556

  Thompson, W Grant ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CIMETROPIUM; DILTIAZEM; DIPHENYLHYDRATE; DOMPERIDONE; LIDAMIDINE; MEBEVERINE; NIFEDIPINE; PEPPERMINT OIL; PROFINIUM; TIMOLOL; TRICYCLAMOL; TRIMEBUTINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANALYTIC METHOD; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; DEFECATION HABIT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; ENTEROPATHY; HUMAN; IRRITABLE COLON; ORGANIZATION; PATHOGENESIS; PHYSICIAN; PRIORITY JOURNAL; PROCTALGIA; QUESTIONNAIRE; SIGMOIDOSCOPY; SOCIAL PSYCHOLOGY; VALIDATION PROCESS;

EID: 33646205453     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.03.011     Document Type: Article

References (41)

1. Klein K.B. Controlled treatment trials in the irritable bowel syndrome. a critique. Gastroenterology 95 (1988) 232-241
2. Powell R. On certain painful afflictions of the intestinal canal. Med Trans Royal Coll Phys 6 (1818) 106-117
3. Howship J. Practical remarks on the discrimination and successful treatment of spasmodic stricture of the colon (1830), Burgess and Hill, London
4. Cumming W. Electro-galvanism in a peculiar affliction of the mucous membrane of the bowels. London Med Gazette NS9 (1849) 969-973
5. Hale-White W. Colitis. Lancet 1 (1895) 537
6. Thompson W.G. Gut reactions (1989), Plenum, New York
7. Hutchison R. Lectures on dyspepsia (1927), Edward Arnold, London
8. Thompson W.G. Proctalgia fugax. Dig Dis Sci 26 (1981) 1121-1124
9. Chaudhary N.A., and Truelove S.C. The irritable colon syndrome. Q J Med 31 (1962) 307-322
10. Thompson W.G. The irritable gut (1979), University Park Press, Baltimore
11. Manning A.P., Thompson W.G., Heaton K.W., and Morris A.F. Towards positive diagnosis of the irritable bowel. Br Med J 2 (1978) 653-654
12. Kruis W., Thieme C.H., Weinzierl M., Schussler P., Hall J., and Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 87 (1984) 1-7
13. Drossman D.A., Sandler R.S., McKee D.C., and Lovitz A.J. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 83 (1982) 529-534
14. Whitehead W.E., Winget C., Fedoravicius A.S., Wooley S., and Blackwell B. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci 27 (1982) 202-208
15. Thompson W.G., Dotevall G., Drossman D.A., Heaton K.W., and Kruis W. Irritable bowel syndrome. guidelines for the diagnosis. Gastroenterol Int 2 (1989) 92-95
16. Drossman D.A., Funch-Jensen P., Janssens J., Talley N.J., Thompson W.G., and Whitehead W.E. Identification of subgroups of functional bowel disorders. Gastroenterol Int 3 (1990) 159-172
17. Richter J.E., Baldi F., Clouse R.E., Diamant N.E., Janssens J., and Stiano A. Functional oesophageal disorders. Gastroenterol Int 5 (1992) 3-17
18. Talley N.J., Colin-Jones D., Koch K.L., Koch M., Nyren O., and Stanghellini V. Functional dyspepsia. a classification with guidelines for diagnosis and management. Gastroenterol Int 4 (1991) 145-160
19. Corazziari E., Funch-Jensen P., Hogan W., Tanaka J., and Toouli J. Working team report on functional biliary disorders. Gastroenterol Int 6 (1993) 129-144
20. Thompson W.G., Creed F.H., Drossman D.A., Heaton K.W., and Mazzacca G. Functional bowel disorders and functional abdominal pain. Gastroenterol Int 5 (1992) 75-91
21. Whitehead W.E., Devroede G., Habib F.I., Meunier P., and Wald A. Report of an international workshop on functional disorders of the anorectum. Gastroenterol Int 5 (1992) 92-108
22. Drossman D.A., Richter J.E., Talley N.J., Corazziari E., Thompson W.G., and Whitehead W.E. Functional gastrointestinal disorders (1994), Little, Brown, Boston
23. Drossman D.A., Corazziari E., Talley N.J., Thompson W.G., and Whitehead W.E. Rome II. a multinational consensus document on functional gastrointestinal disorders 45 ed. (1999)
24. Kasich A., and Rafsky J.C. Clinical evaluation of an anticholinergic in the irritable colon syndrome. Am J Gastroenterol 4 (1959) 229-234
25. Connell A.M. Physiological and clinical assessment of the effect of the musculotropic agent mebeverine on the human colon. BMJ 2 (1965) 848-851
26. Tasman-Jones C. Mebeverine in patients with the irritable colon syndrome. double blind study. N Z Med J 1 (1973) 232-235
27. Greenbaum D.S., Ferguson R.K., Kater L.A., et al. A controlled therapeutic study of the irritable bowel syndrome. N Engl J Med 288 (1973) 612-616
28. Piai G., and Mazzacca G. Profinium Bromide in the treatment of the irritable bowel syndrome. Gastroenterology 77 (1979) 500-502
29. Moshal M.G., and Herron M. A clinical trial of trimebutine in spastic colon. J Int Med Res 7 (1979) 231-234
30. Fielding J.F. Double blind trial of trimebutine in the irritable bowel syndrome. Ir Med J 73 (1980) 377-379
31. Luttecke K. A trial of trimebutine in spastic colon. J Int Med Res 6 (1978) 86-88
32. Fielding J.F. Timolol treatment in the irritable bowel syndrome. Digestion 22 (1982) 155-158
33. Cann P.A., Read N.W., and Holdsworth C.C. Oral domperidone. double blind comparison with placebo in irritable bowel syndrome. Gut 24 (1983) 1135-1140
34. Dew M.J., Evans B.K., and Rhodes J. Peppermint oil for the irritable bowel syndrome. Br J Clin Pract 38 (1984) 394-398
35. Flexinos J., Fioramonti J., and Bueno L. Effect of trimebutine on colonic myoelectric activity in IBS patients. Eur J Clin Pharmacol 28 (1985) 181-185
36. Pidgeon F., Craig F., and Fielding J.F. Lack of effect of cimetidine in the irritable bowel syndrome. Ir J Med Sci 154 (1985) 33-34
37. Narducci F., Bassotti G., and Gaburri M. Nifedipine reduces the colonic motor response to eating in patients with the irritable colon syndrome. Am J Gastroenterol 80 (1985) 317-319
38. Perez-Mateo M., Sillero C., Cuesta A., Vazquez N., and Berbegel J. Diltiazem in the treatment of irritable bowel syndrome. Int J Clin Pharmacol Res 5 (1986) 425-427
39. 2 agonist in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2 (1988) 535-539
40. Dobrilla G., Imbimbo B.P., Piazzi L., and Bensi G. Longterm treatment of IBS with cimetropium bromide. a double blind placebo-controlled clinical trail. Gut 31 (1990) 355-358
41. Thompson W.G., Longstreth G.F., Drossman D.A., Heaton K.W., Irvine E.J., and Muller-Lissner S.A. Functional bowel disease and functional abdominal pain. Gut 45 (1999) 43-47